Clinical Trial Update: A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating sitagliptin for type 2 diabetes mellitus patients with inadequate glycemic control on diet and exercise, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Status: COMPLETED | Results posted: 2009-09-25